Tezosentan shows potential for treating heart failure

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1282, 2001-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating Heart Failure in Older and Oldest Old Patients

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1659-1664

Bentham Science Publishers

Access to resources Recommend Favorite

Pilot study shows carvedilol promising in paediatric heart failure

By  

Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Trimetazidine may be beneficial in treating patients with heart failure, regardless of disease etiology

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Potential Mechanisms of Benefit with Thalidomide in Chronic Heart Failure

By Aukrust Pål   Yndestad Arne  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 2, 2007-01 ,pp. : 127-134

Adis International

Access to resources Recommend Favorite

Heart failure management: potential for huge cost savings

By  

Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite